Скачать или смотреть How Cytiva is leading advancements in therapeutics and biotech

Cytiva is at the forefront of biotech advancement, driving innovation and delivering solutions that transform biotechnology manufacturing and therapeutics. In this video, Emmanuel Ligner, former President and CEO of Cytiva, shares insights into the company’s recent acquisitions — VanRx, GoSilico, and Precision NanoSystems — and how these strategic moves are enhancing workflows across the biotech industry.

These acquisitions reflect our commitment to advancing biotech innovation and creating comprehensive solutions to meet the evolving needs of researchers and manufacturers. By integrating cutting-edge technologies, Cytiva is building a more streamlined and efficient approach to therapeutic development and biotech manufacturing, enabling scientists to tackle challenges at every stage, from discovery to production.

• VanRx brings advanced robotic aseptic filling systems to our portfolio, improving scalability and sterility in drug manufacturing.
• GoSilico delivers in silico modeling software for bioprocess development, accelerating timelines and reducing costs.
• Precision NanoSystems adds expertise in nanoparticle-based medicines, including mRNA therapeutics, opening up new possibilities in precision medicine.

By combining these innovations with our existing expertise, the company is empowering researchers to work faster and smarter while ensuring quality and consistency in their results. These advancements are enabling the development of life-saving medicines and therapies that can reach patients more quickly and efficiently.

Learn more about how Cytiva is shaping the future of therapeutics and biotech:

Discover our comprehensive solutions: https://www.cytivalifesciences.com/

Explore the stories behind our advancements: https://www.cytivalifesciences.com/en...

Our dedication to biotechnology advancement is helping to shape the future of therapeutics and empowers scientists worldwide. Together, we’re pushing the boundaries of what’s possible in biotech.

Chapters
00:00:00 Introduction to Cytiva: a legacy in life sciences
00:00:48 Advancing therapeutics with Danaher Corporation
00:01:33 Progress in in-silico process optimisation
00:02:19 Exciting team expansion and acquisitions in gene therapy
00:03:12 Revolutionary mRNA therapies with lipid nanoparticles
00:03:59 Strategic expansion
00:04:46 Supporting therapeutics from discovery to manufacturing
00:05:32 Expansion with VanRx and Precision NanoSystems
00:06:12 Centres of Excellence in biotech innovation

#therapeutics #biopharma #cytiva #lifesciences